These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9608400)

  • 1. Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres.
    Lin SY; Chen KS; Teng HH
    J Microencapsul; 1998; 15(3):383-90. PubMed ID: 9608400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective colloids and polylactic acid co-affecting the polymorphic crystal forms and crystallinity of indomethacin encapsulated in microspheres.
    Lin SY; Chen KS; Teng HH
    J Microencapsul; 1999; 16(6):769-76. PubMed ID: 10575628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection.
    Gander B; Wehrli E; Alder R; Merkle HP
    J Microencapsul; 1995; 12(1):83-97. PubMed ID: 7730960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.
    Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B
    J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of solvent/non-solvent ratio on microsphere formation using the solvent removal method.
    Godbee J; Scott E; Pattamunuch P; Chen S; Mathiowitz E
    J Microencapsul; 2004 Mar; 21(2):151-60. PubMed ID: 15198427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on preparation process of artesunate polylactic acid microspheres].
    Pan XW; Wang W; Fang HY; Wang FG; Cai ZB
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4071-5. PubMed ID: 24791491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric microspheres prepared by spraying into compressed carbon dioxide.
    Bodmeier R; Wang H; Dixon DJ; Mawson S; Johnston KP
    Pharm Res; 1995 Aug; 12(8):1211-7. PubMed ID: 7494836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.
    Bodmeier R; McGinity JW
    J Microencapsul; 1987; 4(4):279-88. PubMed ID: 3504509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.
    Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y
    Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres.
    Bodmeier R; McGinity JW
    J Microencapsul; 1987; 4(4):289-97. PubMed ID: 3504510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique.
    Ugwoke MI; Kinget R
    J Microencapsul; 1998; 15(3):273-81. PubMed ID: 9608392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
    Takami T; Murakami Y
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulation and controlled release of insulin from polylactic acid microcapsules.
    Lin SY; Ho LT; Chiou HL
    Biomater Med Devices Artif Organs; 1985-1986; 13(3-4):187-201. PubMed ID: 3915873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method.
    Uchida T; Yoshida K; Goto S
    J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2003; 20(1):57-65. PubMed ID: 12519702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.
    Bodmeier R; McGinity JW
    J Microencapsul; 1988; 5(4):325-30. PubMed ID: 3236152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
    Thomasin C; Merkle HP; Gander B
    J Pharm Sci; 1998 Mar; 87(3):269-75. PubMed ID: 9523977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
    Atuah KN; Walter E; Merkle HP; Alpar HO
    J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.